Five years of data, unified into a single story.
Quest Diagnostics•11 markers
| Marker | Value | Status | Delta |
|---|---|---|---|
| hs-CRP Inflammation | 0.6 mg/L | optimal | ↓ 0.4 |
| ALT Liver & Kidney | 21.1 U/L | optimal | ↓ 1.9 |
| Vitamin D Vitamins | 58.4 ng/mL | optimal | ↓ 0.7 |
| HbA1c Metabolic | 5.1 % | optimal | ↑ 0.1 |
| Fasting Glucose Metabolic | 86.2 mg/dL | optimal | ↓ 1.3 |
| LDL Cholesterol Metabolic | 95.1 mg/dL | optimal | ↓ 1.1 |
| Fasting Insulin Metabolic | 6.2 uIU/mL | optimal | ↑ 0.6 |
| Vitamin B12 Vitamins | 369.7 pg/mL | optimal | ↓ 38.9 |
| Total Testosterone Hormones | 826.9 ng/dL | optimal | ↑ 91.8 |
| TSH Thyroid | 1.8 uIU/mL | optimal | ↓ 0.1 |
| Ferritin Iron | 148.4 ng/mL | optimal | ↓ 9.4 |
LabCorp•11 markers
Quest Diagnostics•11 markers
First report where all metabolic markers — glucose, HbA1c, lipids, and insulin — are simultaneously optimal. This represents a meaningful improvement from the borderline readings in 2021.
LabCorp•11 markers
Quest Diagnostics•11 markers
LabCorp•11 markers
Quest Diagnostics•11 markers
hs-CRP reached 4.1 mg/L — double the optimal threshold. ALT was simultaneously elevated. This pattern is consistent with a period of physiological stress. Both normalised within two reports.
LabCorp•11 markers
Quest Diagnostics•11 markers
First of four consecutive reports showing Vitamin D below optimal. A supplementation protocol appears to have begun around June 2022, with levels reaching the optimal range by January 2023 and remaining there.
LabCorp•11 markers
Quest Diagnostics•11 markers